ABSTRACT
Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are two predominant histological types of nonmelanoma skin cancer (NMSC), lacking effective early diagnostic markers. In this study, we assessed the diagnostic value of autoantibodies against p53, MMP-7, and Hsp70 in skin SCC and BCC. ELISA was performed to detect levels of autoantibodies in sera from 101 NMSC patients and 102 normal controls, who were recruited from the Cancer Hospital of Shantou University Medical College. A receiver operator characteristic curve was used to evaluate the diagnostic value. The serum levels of autoantibodies against p53, MMP-7, and Hsp70 were higher in NMSCs than those in the normal controls (all P < 0.01). The AUC of the three-autoantibody panel was 0.841 (95% CI: 0.788-0.894) with the sensitivity and specificity of 60.40% and 91.20% when differentiating NMSCs from normal controls. Furthermore, measurement of this panel could differentiate early-stage skin cancer patients from normal controls (AUC: 0.851; 95% CI: 0.793-0.908). Data from Oncomine showed that the level of p53 mRNA was elevated in BCC (P < 0.05), and the Hsp70 mRNA was upregulated in SCC (P < 0.001). This serum three-autoantibody panel might function in assisting the early diagnosis of NMSC.
Subject(s)
Autoantibodies/immunology , Biomarkers, Tumor/metabolism , HSP70 Heat-Shock Proteins/immunology , Matrix Metalloproteinase 7/immunology , Skin Neoplasms/diagnosis , Tumor Suppressor Protein p53/immunology , Adult , Female , Humans , Infant, Newborn , MaleABSTRACT
OBJECTIVE: To assess the potential impact of mutant ECM amino acids (AA) on melanoma-related matrix metalloproteinase-7 (MMP7) activity. DESIGN AND METHODS: We applied a novel scripted algorithm, based on the MEROPS database, to reveal mutant-dependent sensitivity changes across the cancer genome atlas, melanoma dataset. RESULTS: This approach revealed a strong bias in favor of mutant AA dependent protease sensitivity increases. Thus, melanoma specimens with relatively few mutations had only MMP7 mutant sensitive, ECM peptides. As mutations increased, melanoma specimens included mutant AA representing mostly increased sensitivity and a small but increasing number of mutant AA representing decreased MMP7 sensitivity. There was no detection of melanoma specimens with only decreases in MMP7 sensitivity. Furthermore, melanoma specimens with exclusively increased sensitivity and thereby only a few overall mutations represented reduced T-cell infiltrates and worse outcomes. CONCLUSIONS: Overall, the results indicated that changes in MMP7 sensitivity, attributable to mutant AA, have the potential of identifying patients with distinct survival outcomes as well as patients with cancer specimen immune activity.
Subject(s)
Algorithms , Databases, Genetic , Extracellular Matrix , Matrix Metalloproteinase 7 , Melanoma , Mutation , Neoplasm Proteins , T-Lymphocytes/metabolism , Disease-Free Survival , Extracellular Matrix/genetics , Extracellular Matrix/immunology , Extracellular Matrix/metabolism , Female , Humans , Male , Matrix Metalloproteinase 7/genetics , Matrix Metalloproteinase 7/immunology , Matrix Metalloproteinase 7/metabolism , Melanoma/genetics , Melanoma/immunology , Melanoma/metabolism , Melanoma/mortality , Neoplasm Proteins/genetics , Neoplasm Proteins/immunology , Neoplasm Proteins/metabolism , Survival Rate , T-Lymphocytes/immunologyABSTRACT
In tuberculosis (TB), the innate inflammatory immune response drives tissue destruction, morbidity, and mortality. Monocytes secrete matrix metalloproteinases (MMPs), which have key roles in local tissue destruction and cavitation. We hypothesized that integrin signaling might regulate monocyte MMP secretion in pulmonary TB during cell adhesion to the extracellular matrix (ECM). Adhesion to type I collagen and fibronectin by Mycobacterium tuberculosis-stimulated monocytes increased MMP-1 gene expression by 2.6-fold and 4.3-fold respectively, and secretion by 60% (from 1208.1 ± 186 to 1934.4 ± 135 pg/ml; p < 0.0001) and 63% (1970.3 ± 95 pg/ml; p < 0.001). MMP-10 secretion increased by 90% with binding to type I collagen and 55% with fibronectin, whereas MMP-7 increased 57% with collagen. The ECM did not affect the secretion of tissue inhibitors of metalloproteinases-1 or -2. Integrin αVß3 surface expression was specifically upregulated in stimulated monocytes and was further increased after adhesion to type I collagen. Binding of either ß3 or αV integrin subunits increased MMP-1/10 secretion in M. tuberculosis-stimulated monocytes. In a cohort of TB patients, significantly increased integrin ß3 mRNA accumulation in induced sputum was detected, to our knowledge, for the first time, compared with control subjects (p < 0.05). Integrin αVß3 colocalized with areas of increased and functionally active MMP-1 on infected monocytes, and αVß3 blockade markedly decreased type I collagen breakdown, and impaired both monocyte adhesion and leukocyte migration in a transwell system (p < 0.0001). In summary, our data demonstrate that M. tuberculosis stimulation upregulates integrin αVß3 expression on monocytes, which upregulates secretion of MMP-1 and -10 on adhesion to the ECM. This leads to increased monocyte recruitment and collagenase activity, which will drive inflammatory tissue damage.
Subject(s)
Cell Adhesion , Cell Movement , Extracellular Matrix/metabolism , Integrin alphaVbeta3/genetics , Monocytes/immunology , Mycobacterium tuberculosis/immunology , Collagen Type I/metabolism , Collagenases/metabolism , Extracellular Matrix/drug effects , Fibronectins/metabolism , Gene Expression Regulation , Humans , Integrin alphaVbeta3/antagonists & inhibitors , Integrin alphaVbeta3/immunology , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 10/immunology , Matrix Metalloproteinase 10/metabolism , Matrix Metalloproteinase 7/immunology , Matrix Metalloproteinase 7/metabolism , Matrix Metalloproteinase Inhibitors/pharmacology , Monocytes/microbiology , Monocytes/physiology , Signal Transduction , Sputum/chemistry , Up-RegulationABSTRACT
In the USA, increased cerebrospinal fluid (CSF) inflammatory cytokines have been observed in antiretroviral therapy (ART)-naive, HIV-seropositive individuals with HIV-associated neurocognitive disorder (HAND). We characterized the relationship between HAND and CSF biomarker expression in ART-naive, HIV-seropositive individuals in Rakai, Uganda. We analyzed CSF of 78 HIV-seropositive, ART-naive Ugandan adults for 17 cytokines and 20 neurodegenerative biomarkers via Luminex multiplex assay. These adults underwent neurocognitive assessment to determine their degree of HAND. We compared biomarker concentrations between high and low CD4 groups and across HAND classifications, adjusting for multiple comparisons. Individuals with CD4 <200 cells/µL (N = 38) had elevated levels of CSF Interleukin (IL)-2, IL-12, granulocyte-macrophage colony-stimulating factor (GM-CSF), TNF-α, matrix metalloproteinase (MMP)-1, MMP-7, and S100 calcium-binding protein B (S100B) and lower levels of amyloid ß42. Individuals with CD4 351-500 cells/µL (N = 40) had significantly higher CSF levels of interleukin (IL)-1ß, amyloid ß42, and soluble receptor for advanced glycation end products (sRAGE). Increasing levels of S100B, platelet-derived growth factor-AA (PDGF-AA), brain-derived neurotrophic factor (BDNF), and sRAGE were associated with decreased odds of mild neurocognitive disorder (n = 22) or HIV-associated dementia (n = 15) compared with normal function (n = 30) or asymptomatic neurocognitive impairment (n = 11). Increased levels of interferon (IFN)-γ were associated with increased odds of mild neurocognitive impairment or HIV-associated dementia relative to normal or asymptomatic neurocognitive impairment. Proinflammatory CSF cytokines, chemokines, and neurodegenerative biomarkers were present in increasing concentrations with advanced immunosuppression and may play a role in the development of HAND. The presence of select CNS biomarkers may also play a protective role in the development of HAND.
Subject(s)
AIDS Dementia Complex/cerebrospinal fluid , AIDS Dementia Complex/diagnosis , CD4-Positive T-Lymphocytes/immunology , AIDS Dementia Complex/immunology , AIDS Dementia Complex/physiopathology , Adult , Amyloid beta-Peptides/cerebrospinal fluid , Amyloid beta-Peptides/immunology , Biomarkers/cerebrospinal fluid , Brain-Derived Neurotrophic Factor/cerebrospinal fluid , Brain-Derived Neurotrophic Factor/immunology , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/pathology , Female , Granulocyte-Macrophage Colony-Stimulating Factor/cerebrospinal fluid , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Humans , Interleukin-12/cerebrospinal fluid , Interleukin-12/immunology , Interleukin-2/cerebrospinal fluid , Interleukin-2/immunology , Male , Matrix Metalloproteinase 1/cerebrospinal fluid , Matrix Metalloproteinase 1/immunology , Matrix Metalloproteinase 7/cerebrospinal fluid , Matrix Metalloproteinase 7/immunology , Middle Aged , Neuropsychological Tests , Peptide Fragments/cerebrospinal fluid , Peptide Fragments/immunology , Platelet-Derived Growth Factor/cerebrospinal fluid , Platelet-Derived Growth Factor/immunology , Prospective Studies , Receptor for Advanced Glycation End Products/blood , Receptor for Advanced Glycation End Products/immunology , S100 Calcium Binding Protein beta Subunit/cerebrospinal fluid , S100 Calcium Binding Protein beta Subunit/immunology , Tumor Necrosis Factor-alpha/cerebrospinal fluid , Tumor Necrosis Factor-alpha/immunology , UgandaABSTRACT
Tissue damage is usually regarded as a necessary price to pay for successful elimination of pathogens by the innate immune defense. Yet, it is possible to distinguish protective from destructive effects of innate immune activation and selectively attenuate molecular nodes that create pathology. Here, we identify acute cystitis as an Interleukin-1 beta (IL-1ß)-driven, hyper-inflammatory condition of the infected urinary bladder and IL-1 receptor blockade as a novel therapeutic strategy. Disease severity was controlled by the mechanism of IL-1ß processing and mice with intact inflammasome function developed a moderate, self-limiting form of cystitis. The most severe form of acute cystitis was detected in mice lacking the inflammasome constituents ASC or NLRP-3. IL-1ß processing was hyperactive in these mice, due to a new, non-canonical mechanism involving the matrix metalloproteinase 7- (MMP-7). ASC and NLRP-3 served as transcriptional repressors of MMP7 and as a result, Mmp7 was markedly overexpressed in the bladder epithelium of Asc-/- and Nlrp3-/- mice. The resulting IL-1ß hyper-activation loop included a large number of IL-1ß-dependent pro-inflammatory genes and the IL-1 receptor antagonist Anakinra inhibited their expression and rescued susceptible Asc-/- mice from bladder pathology. An MMP inhibitor had a similar therapeutic effect. Finally, elevated levels of IL-1ß and MMP-7 were detected in patients with acute cystitis, suggesting a potential role as biomarkers and immunotherapeutic targets. The results reproduce important aspects of human acute cystitis in the murine model and provide a comprehensive molecular framework for the pathogenesis and immunotherapy of acute cystitis, one of the most common infections in man. TRIAL REGISTRATION: The clinical studies were approved by the Human Ethics Committee at Lund University (approval numbers LU106-02, LU236-99 and Clinical Trial Registration RTP-A2003, International Committee of Medical Journal Editors, www.clinicaltrials.gov).
Subject(s)
Cystitis/genetics , Cystitis/immunology , Interleukin-1beta/immunology , Matrix Metalloproteinase 7/immunology , Acute Disease , Animals , Blotting, Western , Disease Models, Animal , Electrophoretic Mobility Shift Assay , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunohistochemistry , Immunoprecipitation , Interleukin-1beta/genetics , Male , Matrix Metalloproteinase 7/genetics , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Polymerase Chain Reaction , Transcriptome , TransfectionABSTRACT
PURPOSE: The present study was conducted to evaluate the diagnostic and prognostic values of serum autoantibody against matrix metalloproteinase-7 (MMP-7) in patients with oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: Anti-MMP-7 antibodies were measured in sera from 204 patients with OSCC and 212 normal controls using enzyme-linked immunosorbent assay, and clinicopathologic characteristics were correlated. Prognostic consequence was assessed with Kaplan-Meier curve and log-rank tests using Cox proportional hazard models. To check whether anti-MMP-7 antibody was related to tumor associated antigen, real-time polymerase chain reaction and western blot were used to measure MMP-7 mRNA and protein expression in tumor tissues from all 204 patients with OSCC. RESULTS: Serum anti-MMP-7 antibody was higher in patients with OSCC (P < .05), and those with poorly differentiated tumors had more anti-MMP-7 antibody than those with well to moderate tumor differentiation (P < .01, P < .01, respectively). Patients with OSCC at late TNM stages (III, IV) and lymph node metastases had relatively higher serum anti-MMP-7 antibody levels than those with earlier stages (I, II) and those who lacked lymph node metastases (P < .05 for the 2 comparisons). OSCC prediction sensitivity as measured by receiver operating characteristics analysis was 0.485 and specificity was 0.896 (area under the curve, 0.761; 95% confidence interval, 0.716 to 0.806). Cox analysis showed that serum anti-MMP-7 antibody positivity independently predicted poor overall survival in patients with OSCC (hazard ratio, 1.82; 95% confidence interval, 1.07 to 4.61). MMP-7 mRNA and protein expression was increased in tumor tissues from patients with OSCC and high serum anti-MMP-7 antibody. CONCLUSION: Serum anti-MMP-7 antibody might be a novel diagnostic and prognostic biomarker for OSCC.
Subject(s)
Autoantibodies/blood , Biomarkers, Tumor/blood , Carcinoma, Squamous Cell/diagnosis , Matrix Metalloproteinase 7/immunology , Mouth Neoplasms/diagnosis , Aged , Area Under Curve , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/pathology , Case-Control Studies , Electrophoresis, Polyacrylamide Gel/methods , Female , Follow-Up Studies , Humans , Lymphatic Metastasis/pathology , Male , Matrix Metalloproteinase 7/analysis , Middle Aged , Mouth Neoplasms/blood , Mouth Neoplasms/pathology , Neoplasm Grading , Neoplasm Staging , Prognosis , Proportional Hazards Models , ROC Curve , Retrospective Studies , Sensitivity and Specificity , Survival RateABSTRACT
In this study, the functions and mechanisms of γ δ T cells were analyzed in patients infected with Helicobacter pylori. Peripheral blood was collected from gastritis patients in the Gastroenterology Department of Ningbo No. 2 Hospital. Preliminary analyses revealed 24 H. pylori-positive and 17 H. pylori-negative patients. The wild-type and γ δ T knockout mice were infected with cultured H. pylori cells (obtained from the H. pylori-positive patients). H. pylori in mice was quantified by polymerase chain reaction; gastritis was confirmed by hematoxylin and eosin staining. The TCR-δ(-/-) mice were treated with vein adoptive immunotherapy 24 h prior to H. pylori inoculation; the same method was used to detect the extent of gastritis and bacterial colonization. The γ δ T knockout mice showed high levels of H. pylori infection than the wild-type mice; in addition, the knockout mice showed severe disease pathology. γ δ T knockout mice also displayed increased matrix metalloproteinase-9 (MMP-9) and decreased MMP-7 expression in the gastric mucosa. γ δ T cells play a protective role in patients infected with H. pylori. γ δ T cell [responsible for the production of interleukin-17 (IL-17) and IL-22] expression was increased in H. pylori-positive patients, indicating statistical significance. However, there was no significant difference in interferon-gamma + γ δ T expression between the positive and negative patients. This study demonstrated the probable involvement of γ δ T cells in the immune response of an organism, via the secretion of IL-17 and IL-22.
Subject(s)
Gastritis/immunology , Helicobacter Infections/immunology , Helicobacter pylori/pathogenicity , Immune Tolerance , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocytes/immunology , Animals , Gastric Mucosa/immunology , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastritis/genetics , Gastritis/microbiology , Gastritis/therapy , Gene Expression Regulation , Helicobacter Infections/genetics , Helicobacter Infections/microbiology , Helicobacter Infections/therapy , Helicobacter pylori/immunology , Humans , Immunotherapy, Adoptive , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-17/genetics , Interleukin-17/immunology , Interleukins/genetics , Interleukins/immunology , Matrix Metalloproteinase 7/genetics , Matrix Metalloproteinase 7/immunology , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Antigen, T-Cell, gamma-delta/deficiency , Receptors, Antigen, T-Cell, gamma-delta/genetics , Severity of Illness Index , T-Lymphocytes/microbiology , T-Lymphocytes/pathology , T-Lymphocytes/transplantation , Interleukin-22ABSTRACT
The role of MMPs (matrix metalloproteinases) in kidney diseases has been widely accepted, where they can regulate inflammatory response because of their effects on both recruitment and survival of inflammatory cells. TNFα (tumour necrosis factor α) has also been implicated in the pathogenesis of inflammatory kidney diseases, including forms of glomerulonephritis associated with viral diseases. Previously, we established the functional linkage between viral receptors of the innate immune system, the TLRs (Toll-like receptors) and control of MMP activity in human MC (mesangial cells). Expression levels of MMP-2, MMP-7, MMP-9, TIMP-1 (tissue inhibitor of metalloproteinase 1) and TIMP-2 in human MC in culture were analysed by RT-PCR (reverse transcription-PCR). TNFα significantly enhanced the TLR3-dependent induction of MMP-9 in human MC. Expression levels of MMP-2, TIMP-1 and TIMP-2 were not significantly affected by the activation of TLR3 or TNFα stimulation. No significant MMP-7 expression was found. We conclude that the role of MMP-9 in chemotaxis, activation and proliferation of inflammatory cells is amplified by TNFα originating from infiltrating cells, especially monocytes, producing a regulatory loop that potentially leads to a self-propagating inflammation.
Subject(s)
Matrix Metalloproteinase 9/genetics , Mesangial Cells/immunology , Toll-Like Receptor 3/immunology , Tumor Necrosis Factor-alpha/immunology , Cell Line , Gene Expression Regulation , Hepacivirus/immunology , Hepatitis C/immunology , Hepatitis C/virology , Humans , Interferon Inducers/immunology , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 2/immunology , Matrix Metalloproteinase 7/genetics , Matrix Metalloproteinase 7/immunology , Matrix Metalloproteinase 9/immunology , Mesangial Cells/metabolism , Mesangial Cells/virology , Poly I-C/immunology , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-1/immunology , Tissue Inhibitor of Metalloproteinase-2/genetics , Tissue Inhibitor of Metalloproteinase-2/immunology , Toll-Like Receptor 3/genetics , Up-RegulationABSTRACT
AIM: To evaluate the diagnostic values of serum autoantibodies against matrix metalloproteinase-7 (MMP-7) in patients with esophageal squamous cell carcinoma (ESCC). METHODS: The MMP-7 cDNA was cloned from ESCC tissues, and MMP-7 was expressed and purified from a prokaryotic system. MMP-7 autoantibodies were then measured in sera from 50 patients with primary ESCC and 58 risk-matched controls, using a reverse capture enzyme-linked immunosorbent assay (ELISA) in which autoantibodies to MMP-7 bound to the purified MMP-7 proteins. In addition, MMP-7 autoantibody levels in sera from 38 gastric cancer patients and from control serum samples were also tested. RESULTS: The optimum conditions for recombinant MMP-7 protein expression were determined as 0.04 mmol/L Isopropyl-ß-D-Thiogalactopyranoside (IPTG) induction at 37°C for four hours. The levels of serum autoantibodies against MMP-7 were significantly higher in patients with ESCC than in the matched-control samples (OD450 = 1.69 ± 0.08 vs OD450 = 1.55 ± 0.10, P < 0.001). The area under the receiver operating characteristic (ROC) curve was 0.87. The sensitivity and specificity for detection of ESCC were 78.0% and 81.0%, respectively, when the OD450 value was greater than 1.65. Although the levels of autoantibodies against MMP-7 were also significantly higher in patients with gastric cancer compared to control samples (OD450 = 1.62 ± 0.06 vs OD450 = 1.55 ± 0.10, P < 0.001), the diagnostic accuracy was less significant than in ESCC patients. The area of ROC curve was 0.75, whereas the sensitivity and specificity were 60.5% and 71.7%, respectively, when the cut-off value of OD450 was set at 1.60. CONCLUSION: Serum autoantibody levels of MMP-7 may be a good diagnostic biomarker for esophageal squamous cell carcinoma.
Subject(s)
Autoantibodies/chemistry , Biomarkers, Tumor/metabolism , Biomarkers/metabolism , Carcinoma, Squamous Cell/immunology , Esophageal Neoplasms/immunology , Matrix Metalloproteinase 7/immunology , Aged , Carcinoma, Squamous Cell/diagnosis , Case-Control Studies , Cell Line, Tumor , Cloning, Molecular , Esophageal Neoplasms/diagnosis , Female , Humans , Isopropyl Thiogalactoside/pharmacology , Male , Matrix Metalloproteinase 7/biosynthesis , Middle Aged , ROC Curve , Sensitivity and SpecificityABSTRACT
BACKGROUND: Healing of the epithelium is a key consideration in gastrointestinal surgery. Inflammation is one factor innate to patients with inflammatory bowel disease that poses a risk of delayed healing of the intestinal epithelium postoperatively. MATERIALS AND METHODS: Epithelial wounding model was performed on rat intestinal epithelial cells grown under control and interferon gamma (IFN-γ)-, interleukin-1beta (IL-1ß)-, and tumor necrosis factor-alpha (TNF-α)-stimulated conditions. Wounds were measured and percent healing was calculated at 0, 8 and 24 h. Western blot analysis was performed using matrix metalloproteinase (MMP)-7 primary antibody and semiquantitative densitometry was conducted. RESULTS: Wounds were 50.0% and 99.7% healed under control conditions at 8 and 24 h, respectively. IL-1ß and IFN-γ delayed wound closure. MMP-7 increased by 2.3-fold at 8 h and 1.6-fold at 24 h during wound healing. Activated MMP-7 increased by 3- to 5-fold at 24 h. IL-1ß stimulation increased levels of MMP-7 by 17% to 37% above the elevated expression due to healing alone. TNF-α up-regulated MMP-7 in non-wounded and wounded cells, and IFN-γ did not affect its expression. When MMP-7 activity was blocked, wound closure was delayed. CONCLUSIONS: MMP-7 significantly contributes to intestinal epithelial wound closure evidenced by: (1) presence of increased MMP-7 during healing under control conditions and (2) the delayed rate of closure when MMP-7 activity was blocked. IL-1ß increased MMP-7 levels beyond those seen during normal healing. It appears that some increase in MMP-7 is necessary for normal wound closure; however, its overexpression may delay intestinal epithelial wound healing, especially when MMP-7 is up-regulated by cytokines present in the inflammatory environment of inflammatory bowel disease (IBD).
Subject(s)
Inflammatory Bowel Diseases/enzymology , Intestinal Mucosa/enzymology , Matrix Metalloproteinase 7/metabolism , Wound Healing , Anastomotic Leak/etiology , Animals , Antibodies , Cell Line, Tumor , Epithelial Cells/enzymology , Humans , Inflammatory Bowel Diseases/complications , Interleukin-1beta/metabolism , Matrix Metalloproteinase 7/immunology , Matrix Metalloproteinase Inhibitors , RatsABSTRACT
BACKGROUND: Bronchial epithelial damage and activation likely contribute to the inflammatory and airway-remodeling events characteristic of severe asthma. Interaction of Fas receptor (CD95) with its ligand (FasL; CD95L) is an important mechanism of cell-mediated apoptosis. Bronchial epithelial FasL expression provides immune barrier protection from immune cell-mediated damage. OBJECTIVES: Membrane FasL (mFasL) is a cleavage target of matrix metalloproteinases (MMPs). We investigated whether the asthmatic T(H)2 environment might influence disease processes by increasing airway epithelial MMP-mediated cleavage of mFasL into proinflammatory soluble FasL. METHODS: We used human airway epithelial cell lines and primary cells to model the human airway epithelium in vitro. Airway tissue from healthy subjects and patients with severe asthma was used to investigate MMP expression patterns in diseased airways. RESULTS: We demonstrate that active MMP-7 is present in the ciliated epithelial cells of normal human airways. In patients with severe asthma, MMP-7 levels are increased in basal epithelial cells. Airway epithelial cell lines (1HAEo(-) and 16HBE14o(-)) in vitro express constitutively high levels of MMP-2 and MMP-9 but relatively low levels of MMP-7. T(H)2 cytokine (IL-4, IL-9, and IL-13) treatment of 1HAEo(-) cells increased MMP-7 mRNA and activity, triggered colocalization of intracellular MMP-7 with FasL, and caused mFasL cleavage with soluble FasL release. Small interfering RNA knockdown shows that cytokine-induced mFasL cleavage is dependent on MMP-7 activity. CONCLUSIONS: MMPs serve multiple beneficial roles in the lung. However, chronic disordered epithelial expression of MMP-7 in patients with asthma might increase mFasL cleavage and contribute to airway epithelial damage and inflammation.
Subject(s)
Asthma/immunology , Bronchi/immunology , Epithelial Cells/immunology , Fas Ligand Protein/immunology , Interleukin-13/pharmacology , Matrix Metalloproteinase 7/immunology , Respiratory Mucosa/immunology , Th2 Cells/immunology , Asthma/genetics , Asthma/metabolism , Asthma/pathology , Bronchi/metabolism , Bronchi/pathology , Cell Line, Transformed , Epithelial Cells/metabolism , Epithelial Cells/pathology , Fas Ligand Protein/genetics , Fas Ligand Protein/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Enzymologic/genetics , Gene Expression Regulation, Enzymologic/immunology , Humans , Interleukin-13/genetics , Interleukin-13/immunology , Interleukin-13/metabolism , Interleukin-4/genetics , Interleukin-4/immunology , Interleukin-4/metabolism , Interleukin-9/genetics , Interleukin-9/immunology , Interleukin-9/metabolism , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 2/immunology , Matrix Metalloproteinase 7/biosynthesis , Matrix Metalloproteinase 7/genetics , Matrix Metalloproteinase 9/biosynthesis , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/immunology , Models, Biological , RNA, Small Interfering/genetics , RNA, Small Interfering/immunology , Respiratory Mucosa/metabolism , Respiratory Mucosa/pathology , Th2 Cells/metabolism , Th2 Cells/pathology , fas Receptor/genetics , fas Receptor/immunology , fas Receptor/metabolismABSTRACT
Matrix metalloproteinases (MMPs) play a vital role in the pathogenesis of several inflammatory diseases including tuberculosis through tissue remodeling. 1, 25(OH)(2)D(3) has several well recognized biological functions including suppression of MMP production. The influence of 1, 25(OH)(2)D(3) on MMP-7, MMP-9 and tissue inhibitor of metalloproteinase-1 (TIMP-1), production was studied in 43 pulmonary tuberculosis (PTB) patients and 44 healthy controls (HC). Peripheral blood mononuclear cells (PBMCs) were cultured with culture filtrate antigen (CFA) of Mycobacterium tuberculosis (MTB) and live MTB with or without 1, 25(OH)(2)D(3) (10(-7) M) for 48 h and the culture supernatants were assayed for MMP-7, MMP-9, TIMP-1 and cytokines IFN-gamma and TNF-alpha using ELISA. In HC and PTB, the levels of MMP-7, MMP-9 and TIMP-1 were not altered by CFA and live MTB stimulation in both groups. However, a significant decrease in the spontaneous production of MMP-7 (p=0.007), and an increase in MMP-9 (p=0.07) and TIMP-1 (p=0.0001) were observed in PTB patients as compared to HC. Vitamin D(3) significantly reduced the MMP-7 (p=0.0001) and MMP-9 (p=0.0001) and increased the TIMP-1 (p=0.005) level in antigen stimulated and unstimulated cultures of PTB as compared to HC. A significant positive correlation between MMP-9 and IFN-gamma was observed in unstimulated cultures of both HC (p=0.05) and PTB patients (p=0.0007). The present study suggests that 1, 25(OH)(2)D(3) suppresses the production of MMPs and enhances the level of TIMP-1 in tuberculosis. The present study suggests that 1, 25(OH)(2)D(3) may probably play an important role in the pathological process in tuberculosis by downregulating the levels of MMPs and upregulating the levels of TIMPs.
Subject(s)
Calcitriol/pharmacology , Immunologic Factors/pharmacology , Matrix Metalloproteinase Inhibitors , Tissue Inhibitor of Metalloproteinase-1/agonists , Tuberculosis, Pulmonary/immunology , Adult , Cells, Cultured , Female , Humans , Interferon-gamma/immunology , Interferon-gamma/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Male , Matrix Metalloproteinase 7/immunology , Matrix Metalloproteinase 9/immunology , Middle Aged , Mycobacterium tuberculosis , Tissue Inhibitor of Metalloproteinase-1/immunology , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolismABSTRACT
BACKGROUND: Metalloproteinase inhibitors can protect mice against experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS). Matrix metalloproteinase-9 (MMP-9) has been implicated, but it is not clear if other MMPs are also involved, including matrilysin/MMP-7 - an enzyme capable of cleaving proteins that are essential for blood brain barrier integrity and immune suppression. RESULTS: Here we report that MMP-7-deficient (mmp7-/-) mice on the C57Bl/6 background are resistant to EAE induced by myelin oligodendrocyte glycoprotein (MOG). Brain sections from MOG-primed mmp7-/-mice did not show signs of immune cell infiltration of the CNS, but MOG-primed wild-type mice showed extensive vascular cuffing and mononuclear cell infiltration 15 days after vaccination. At the peak of EAE wild-type mice had MMP-7 immuno-reactive cells in vascular cuffs that also expressed the macrophage markers Iba-1 and Gr-1, as well as tomato lectin. MOG-specific proliferation of splenocytes, lymphocytes, CD4+ and CD8+ cells were reduced in cells isolated from MOG-primed mmp7-/- mice, compared with MOG-primed wild-type mice. However, the adoptive transfer of splenocytes and lymphocytes from MOG-primed mmp7-/- mice induced EAE in naïve wild-type recipients, but not naïve mmp7-/- recipients. Finally, we found that recombinant MMP-7 increased permeability between endothelial cells in an in vitro blood-brain barrier model. CONCLUSION: Our findings suggest that MMP-7 may facilitate immune cell access or re-stimulation in perivascular areas, which are critical events in EAE and multiple sclerosis, and provide a new therapeutic target to treat this disorder.
Subject(s)
Central Nervous System/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , Matrix Metalloproteinase 7/deficiency , Matrix Metalloproteinase 7/immunology , Vaccination , Animals , Blood-Brain Barrier/pathology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Calcium-Binding Proteins/metabolism , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Lymphocyte Activation/immunology , Macrophages/immunology , Matrix Metalloproteinase 7/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Microfilament Proteins , Microscopy, Confocal , Multiple Sclerosis , Myelin Proteins , Myelin-Associated Glycoprotein , Myelin-Oligodendrocyte Glycoprotein , Plant Lectins/metabolismABSTRACT
The innate immune response of airway epithelial cells to airborne allergens initiates the development of T cell responses that are central to allergic inflammation. Although proteinase allergens induce the expression of interleukin 25, we show here that epithelial matrix metalloproteinase 7 (MMP7) was expressed during asthma and was required for the maximum activity of interleukin 25 in promoting the differentiation of T helper type 2 cells. Allergen-challenged Mmp7(-/-) mice had less airway hyper-reactivity and production of allergic inflammatory cytokines and higher expression of retinal dehydrogenase 1. Inhibition of retinal dehydrogenase 1 restored the asthma phenotype of Mmp7(-/-) mice and inhibited the responses of lung regulatory T cells, whereas exogenous administration of retinoic acid attenuated the asthma phenotype. Thus, MMP7 coordinates allergic lung inflammation by activating interleukin 25 while simultaneously inhibiting retinoid-dependent development of regulatory T cells.
Subject(s)
Asthma/metabolism , Interleukins/metabolism , Matrix Metalloproteinase 7/metabolism , Respiratory Mucosa/metabolism , Tretinoin/metabolism , Allergens/immunology , Animals , Asthma/immunology , Asthma/pathology , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Cell Differentiation/immunology , Chromatography, High Pressure Liquid , Cytokines/biosynthesis , Cytokines/immunology , Disease Models, Animal , Electrophoresis, Gel, Two-Dimensional , Humans , Immunohistochemistry , Interleukins/immunology , Lymphocyte Activation/immunology , Matrix Metalloproteinase 7/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Proteomics , Respiratory Mucosa/immunology , Retinal Dehydrogenase/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Th2 Cells/cytology , Th2 Cells/immunology , Tretinoin/immunologyABSTRACT
PURPOSE: A prerequisite for the development of vaccination strategies is the identification and characterization of relevant tumor-associated antigen. Using microarray and reverse transcription-PCR analysis, we found matrix metalloproteinase (MMP)-7 to be extensively up-regulated in renal cell carcinomas and expressed in a broad variety of malignant cells. MMP-7 can promote cancer invasion and angiogenesis by proteolytic cleavage of extracellular matrix and basement membrane proteins, thus making it a promising target in the context of immunotherapies. EXPERIMENTAL DESIGN: To analyze the possible use of MMP-7 as a tumor-associated antigen, specific CTLs were induced using monocyte-derived dendritic cells electroporated with MMP-7-mRNA. In addition, to better characterize the fine specificity of these CTLs, MMP-7 MHC class I ligands were isolated and characterized in renal cell carcinoma tissue, which overexpressed MMP-7, by mass spectrometry-based peptide sequencing. Using this approach, we identified a novel HLA-A3-binding antigenic MMP-7 peptide. CTLs generated from healthy donors by in vitro priming with dendritic cells, pulsed with the novel peptide, were used as effectors in (51)Cr-release assays. RESULTS: The induced CTLs elicited an antigen-specific and HLA-restricted cytolytic activity against tumor cells endogenously expressing the MMP-7 protein. Furthermore, we were able to induce MMP-7-specific CTLs using peripheral blood mononuclear cells from a patient with acute lymphoblastic leukemia capable of recognizing the autologous leukemic blasts while sparing nonmalignant cells. CONCLUSIONS: Our study describes the identification of a novel broadly expressed T-cell epitope derived from the MMP-7 protein that represents an interesting candidate to be applied in immunotherapies of human malignancies targeting both tumor cells and neovascularization.
Subject(s)
Antigens, Neoplasm/isolation & purification , Carcinoma, Renal Cell/immunology , Kidney Neoplasms/immunology , Matrix Metalloproteinase 7/isolation & purification , Cell Line, Tumor , Electroporation , Epitopes , Epitopes, T-Lymphocyte/immunology , HLA-A3 Antigen/immunology , Humans , Matrix Metalloproteinase 7/immunology , T-Lymphocytes/immunology , T-Lymphocytes, Cytotoxic/immunology , Up-RegulationABSTRACT
BACKGROUND: No validated renal cell carcinoma (RCC) marker is known for detection of asymptomatic disease in selected populations or for prognostic purposes or treatment monitoring. We identified immunogenic proteins as tumor markers for RCC by combining conventional proteome analysis with serological screening, and we investigated the diagnostic clinical value of such markers in serum. METHODS: We studied the immunogenic protein expression profile of CAL 54, a human RCC cell line, by 2-dimensional electrophoresis combined with immunoblotting using sera from healthy donors compared with RCC patients. We developed a homogeneous, fluorescent, dual-monoclonal immunoassay for metalloproteinase 7 (MMP-7) and used it to measure MMP-7 in sera from 30 healthy donors, 30 RCC patients, and 40 control patients. RESULTS: Pro-MMP-7 (29 kDa; pI 7.7) in the CAL 54 cell line secretome was an immunogenic protein reactive with RCC patient sera but not with control sera. The concentrations of pro-MMP-7 were increased (P <0.0001) in sera of RCC patients (median 7.56 microg/L; range 3.12-30.5 microg/L) compared with healthy controls (median 2.13 microg/L; range 0.17-3.5 microg/L). Serum pro-MMP-7 had a sensitivity of 93% (95% CI 78%-99%) at a specificity of 75% (59%-87%) for RCC in the samples tested. CONCLUSION: Proteomics technology combined with serology led to the identification of serum pro-MMP-7 as a marker of RCC and represents a powerful tool in searching for candidate proteins as biomarkers.
Subject(s)
Biomarkers, Tumor/blood , Carcinoma, Renal Cell/diagnosis , Kidney Neoplasms/diagnosis , Matrix Metalloproteinase 7/blood , Antibodies, Monoclonal , Antibody Specificity , Biomarkers, Tumor/immunology , Carcinoma, Renal Cell/secondary , Cell Line, Tumor , Female , Fluoroimmunoassay , Humans , Isoenzymes/blood , Isoenzymes/immunology , Kidney Neoplasms/pathology , Male , Matrix Metalloproteinase 7/immunology , Protein Precursors/blood , Protein Precursors/immunology , Retrospective Studies , SerumABSTRACT
Matrix metalloproteinases (MMPs) are a family of enzymes named for their ability to degrade proteins of the extracellular matrix. Here we describe the characterization of a rat monoclonal antibody specifically recognizing one member of this enzyme family, MMP-7. This antibody has been tested for its use in multiple assay types and was shown to be useful for direct enzyme-linked immunosorbent assay (ELISA), Western blotting, immunocytochemistry, and immunohistochemistry of frozen or paraffin-embedded tissues. The antibody has been evaluated for its usefulness with tissues from several different species and, by immunohistochemistry, can detect MMP-7 of human, murine, porcine, and gerbil origin. Immunostaining of MMP-7 in normal tissues or benign tumors of intestinal, breast, and prostatic origin indicates that this protein is normally localized luminally in glandular epithelium. The localization pattern would suggest that in normal or early stage tumors, MMP-7 is most likely not directly involved in extracellular matrix degradation. In contrast, advanced colon tumors show MMP-7 in invading cells at the advancing edge of the tumor.
Subject(s)
Antibodies, Monoclonal/physiology , Enzyme Precursors/immunology , Gene Expression Regulation/physiology , Matrix Metalloproteinase 7/immunology , Matrix Metalloproteinase 7/metabolism , Animals , Enzyme Precursors/metabolism , HCT116 Cells , HT29 Cells , Humans , Mice , Rats , Rats, Sprague-DawleyABSTRACT
Scirrhous hepatocellular carcinoma (SHCC) is a rare variation of HCC, for which characteristics of tumor cells and the fibrotic stroma have not been clarified in detail. The present study was therefore carried out to elucidate cytological features of tumor and stromal cells and components of the stromal extracellular matrix in 15 SHCC patients undergoing hepatectomy without preoperative transarterial embolization. Diagnosis was on the basis of a scirrhous histological pattern exceeding 50% of the tumor area. Expression of cytoplasmic and extracellular matrix proteins was compared among SHCC, HCC and intrahepatic cholangiocarcinoma (ICC) cases with immunohistochemical staining. The lesions could be histologically divided into radiating and sinusoidal types. Common stromal components of SHCC and ICC were collagen types I and III. There was no expression of laminin-5 in the stroma of SHCC, but it was present in almost all ICC cases. Tenascin-C expression was significantly lower in the SHCC cases and its distribution differed between SHCC and ICC. Matrix metalloproteinase-7 (MMP-7) expression was significantly higher in SHCC compared with HCC. Almost all stromal cells were alpha-smooth muscle actin-positive both in SHCC and ICC, whereas glial fibrillary acid protein (GFAP)-positive stromal cells were significantly more increased in ICC than in SHCC. SHCC clearly differed from HCC with respect to collagen types I, III and MMP-7 expression, and from ICC with regard to stromal components including laminin-5, tenascin-C and GFAP(+) stromal cells.
Subject(s)
Adenocarcinoma, Scirrhous/pathology , Bile Duct Neoplasms/pathology , Bile Ducts, Intrahepatic/pathology , Carcinoma, Hepatocellular/pathology , Cholangiocarcinoma/pathology , Liver Neoplasms/pathology , Adenocarcinoma, Scirrhous/chemistry , Adenocarcinoma, Scirrhous/immunology , Aged , Apoptosis , Bile Duct Neoplasms/chemistry , Bile Duct Neoplasms/immunology , Bile Ducts, Intrahepatic/chemistry , Bile Ducts, Intrahepatic/immunology , Carcinoma, Hepatocellular/chemistry , Carcinoma, Hepatocellular/immunology , Cell Proliferation , Cholangiocarcinoma/chemistry , Cholangiocarcinoma/immunology , Collagen Type I/analysis , Collagen Type I/immunology , Collagen Type III/analysis , Collagen Type III/immunology , Female , Fibroblast Growth Factor 2/analysis , Fibroblast Growth Factor 2/immunology , Humans , Keratins/analysis , Keratins/immunology , Laminin/analysis , Laminin/immunology , Liver Neoplasms/chemistry , Liver Neoplasms/immunology , Male , Matrix Metalloproteinase 7/analysis , Matrix Metalloproteinase 7/immunology , Middle Aged , Tenascin/analysis , Tenascin/immunologyABSTRACT
Matrix metalloproteinase-7 (MMP-7) (also known as matrilysin-1) is secreted as a proenzyme (proMMP-7) and plays a key role in the degradation of various extracellular matrix (ECM) and non-ECM molecules after activation. To identify the binding proteins related to proMMP-7 activation, a human lung cDNA library was screened by yeast two-hybrid system using proMMP-7 as bait. We identified a candidate molecule CD151, which is a member of the transmembrane 4 superfamily. Complex formation of proMMP-7 with CD151 was demonstrated by immunoprecipitation of the molecules from CaR-1 cells, a human rectal carcinoma cell line, expressing both proMMP-7 and CD151, and CD151 stable transfectants incubated with proMMP-7. Yeast two-hybrid assays using deletion mutants of proMMP-7 and CD151 suggested an interaction between the propeptide of proMMP-7 and the COOH-terminal extracellular loop of CD151. The binding activity of (125)I-labeled proMMP-7 to CD151 on the cell membranes was shown with CD151 stable transfectants. Laser-scanning confocal microscopy demonstrated that proMMP-7 colocalizes with CD151 on the cell membranes of CD151 stable transfectants and CaR-1 cells. In situ zymography using crosslinked carboxymethylated transferrin, a substrate of MMP-7, demonstrated proteinase activity on and around CD151 stable transfectants and CaR-1 cells, while the activity was abolished by their treatment with MMP inhibitors, anti-MMP-7 antibody or anti-CD151 antibody. In human lung adenocarcinoma tissues, colocalization of MMP-7 and CD151 was demonstrated on the carcinoma cells. Metalloproteinase activity was present in these tissues and could be inhibited by antibodies to MMP-7 or CD151. These data demonstrate for the first time that proMMP-7 is captured and activated on the cell membranes through interaction with CD151, and suggest the possibility that similar to the MT1-MMP/MMP-2 system, MMP-7 is involved in the pericellular activation mechanism mediated by CD151, a crucial step in proteolysis on the cell membranes under various pathophysiological conditions including cancer invasion and metastasis.
Subject(s)
Adenocarcinoma/enzymology , Antigens, CD/metabolism , Cell Membrane/enzymology , Lung Neoplasms/enzymology , Matrix Metalloproteinase 7/metabolism , Rectal Neoplasms/enzymology , Adenocarcinoma/pathology , Antibodies, Blocking/pharmacology , Antigens, CD/genetics , Antigens, CD/immunology , Cell Line, Tumor , Cell Membrane/drug effects , Enzyme Activation , Enzyme Inhibitors/pharmacology , Extracellular Matrix/metabolism , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/pathology , Matrix Metalloproteinase 7/genetics , Matrix Metalloproteinase 7/immunology , Neoplasm Invasiveness/physiopathology , Neoplasm Metastasis/physiopathology , Tetraspanin 24 , Transfection , Two-Hybrid System TechniquesABSTRACT
Matrix metalloproteinase 7 (MMP-7), or matrilysin, is a secreted protease expressed by glandular and mucosal epithelial cells, keratinocytes, fibroblasts and macrophages. As with other MMPs it can act on the extracellular matrix and thereby regulate cell migration and tissue repair. In addition, MMP-7 has an important role in the maintenance of innate immunity in organs such as the lungs and intestines where it proteolytically activates anti-bacterial peptides such as pro-defensins. MMP-7 is also important for mediating proteolytic release of TNF from macrophages. Consistent with its role in innate immunity, MMP-7 is induced by microbial products and also, unexpectedly, by hypoxia.